Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tibet Rhodiola Capsule in OSA
NCT03163615Unknown
- Start
- Jun 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in obstructive sleep apnea (OSA) comparing Tibet Rhodiola Capsule with Placebo (2 arms). Primary endpoint: Average oxygen saturation. Status: unknown.
02
Drugs
Tibet Rhodiola Capsule
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT03163615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03163615.